(Q73599503)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

phase II clinical trial

1 reference

C M O'Connor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W A Gattis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T J Ryan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

S143-54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

Surrogate end points in clinical trials: are we being misled?

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Alternatives to mega-trials in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Use of composite endpoints in thrombolysis trials of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

The effect of digoxin on mortality and morbidity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Clinical classification of cardiac deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Interobserver discordance in the classification of mechanisms of death in studies of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effectiveness of preload reserve as a determinant of clinical status in patients with left ventricular systolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

A comparison of reteplase with alteplase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2800%2990062-0

10.1016/S0002-8703(00)90062-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10740121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference